The Corbevax COVID-19 vaccine was developed by researchers in Texas with no patent, and could be the end of global vaccine inequity.

The Corbevax COVID-19 vaccine was developed by researchers in Texas with no patent, and could be the end of global vaccine inequity.
Catch up on some of the most exciting and impactful developments in science from this year, published on ASN and selected by our editors.
Molecular dynamics offer ways to improve lipid-based therapeutic delivery systems.
A fast and efficient means of record keeping could improve the ability to trace structural differences in viral variants.
Preliminary data indicates that booster shots improve antibody levels 25-fold compared to just two doses.
Three potent antibodies against SARS-CoV-2 identified in healthy individuals decades ago raises interesting questions about their origins and evolution.
Antibody therapies and new vaccines have been added to the arsenal, giving hope to the millions who live where malaria is endemic.
With SARS-CoV-2 continuing to circulate, new oral antivirals promise to be game changers in helping to end the pandemic.
With questions centered around cost and how long the transition will take, how do we convince people that the transition to renewables will be worth it?
Researchers have used helical virus particles as chiral templates for growing polymers with magnetic properties.